Arbutus Biopharma Corp. (ABUS)

5.15 +0.03 (+0.59%) USD  |  NASDAQ  |  Sep 04, 16:00
5.15 0.00 (0.00%) Pre-Market: 20:00
More

Arbutus Biopharma EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical EPS LT Growth Estimates Data

View and export this data back to . Start Trial.
Date Value

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Moderna, Inc. Upgrade
Insmed, Inc. --
Pfizer Inc. Upgrade
Gossamer Bio, Inc. --
Legend Biotech Corp. --